Furthermore, CMYC+ tumour cells and the combination of PD-1+ tumour cells and high PD-L1+ group indicated significantly poor prognostic factors in patients with three types of TFH+ PTCLs by uni- and multivariate analyses. This evidence concerns the gene PDCD1 and neoplasm.